![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ENTPD4 mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1319890 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ENTPD4 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | affects expression | ISO | RGD:1319890 | 6480464 | 1, 2-Dimethylhydrazine affects the expression of ENTPD4 mRNA | CTD | PMID:22206623 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1319890 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1319890 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1319890 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ENTPD4 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1319890 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ENTPD4 mRNA | CTD | PMID:21570461 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:1319890 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ENTPD4 mRNA | CTD | PMID:26251327 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1319889 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ENTPD4 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RGD:1319889 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased methylation of ENTPD4 gene | CTD | PMID:31601247 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1319890 | 6480464 | Fenretinide results in increased expression of ENTPD4 mRNA | CTD | PMID:28973697 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of ENTPD4 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | ISO | RGD:1319890 | 6480464 | Aflatoxin B1 results in increased expression of ENTPD4 mRNA | CTD | PMID:19770486 | Aroclor 1254 | decreases expression | ISO | RGD:1319890 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of ENTPD4 mRNA | CTD | PMID:23650126 | atrazine | decreases expression | ISO | RGD:1319890 | 6480464 | Atrazine results in decreased expression of ENTPD4 mRNA | CTD | PMID:26518232 | benzo[a]pyrene | multiple interactions | ISO | RGD:1319890 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to ENTPD4 promoter] | CTD | PMID:19654925 | benzo[a]pyrene | affects methylation | ISO | RGD:1319889 | 6480464 | Benzo(a)pyrene affects the methylation of ENTPD4 5' UTR, Benzo(a)pyrene affects the methylation of ENTPD4 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1319889 | 6480464 | Diethylhexyl Phthalate results in decreased expression of ENTPD4 protein | CTD | PMID:31163220 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ENTPD4 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | RGD:1319889 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ENTPD4 mRNA | CTD | PMID:28628672 | bupivacaine | multiple interactions | EXP | | 6480464 | [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of ENTPD4 mRNA | CTD | PMID:22341215 | cadmium atom | multiple interactions | ISO | RGD:1319889 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ENTPD4 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1319889 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ENTPD4 mRNA | CTD | PMID:35301059 | carbamazepine | affects expression | ISO | RGD:1319889 | 6480464 | Carbamazepine affects the expression of ENTPD4 mRNA | CTD | PMID:24752500 | coumestrol | decreases expression | ISO | RGD:1319889 | 6480464 | Coumestrol results in decreased expression of ENTPD4 mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | RGD:1319890 | 6480464 | Cyclosporine results in increased expression of ENTPD4 mRNA | CTD | PMID:19770486 | cyclosporin A | increases expression | ISO | RGD:1319889 | 6480464 | Cyclosporine results in increased expression of ENTPD4 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | EXP | | 6480464 | [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of ENTPD4 mRNA | CTD | PMID:22341215 | dexamethasone | multiple interactions | ISO | RGD:1319889 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ENTPD4 mRNA | CTD | PMID:28628672 | diclofenac | affects expression | ISO | RGD:1319889 | 6480464 | Diclofenac affects the expression of ENTPD4 mRNA | CTD | PMID:24752500 | dioxygen | increases expression | ISO | RGD:1319889 | 6480464 | Oxygen deficiency results in increased expression of ENTPD4 mRNA | CTD | PMID:20042640 | dorsomorphin | multiple interactions | ISO | RGD:1319889 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:1319889 | 6480464 | Doxorubicin results in decreased expression of ENTPD4 mRNA | CTD | PMID:29803840 | fenthion | decreases expression | ISO | RGD:1319890 | 6480464 | Fenthion results in decreased expression of ENTPD4 mRNA | CTD | PMID:34813904 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of ENTPD4 mRNA | CTD | PMID:30307764 | folic acid | multiple interactions | ISO | RGD:1319890 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ENTPD4 mRNA | CTD | PMID:22206623 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of ENTPD4 gene | CTD | PMID:22079235 | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of ENTPD4 mRNA | CTD | PMID:25539665 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ENTPD4 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | ISO | RGD:1319889 | 6480464 | Hydrogen Peroxide affects the expression of ENTPD4 mRNA | CTD | PMID:21179406 | indometacin | multiple interactions | ISO | RGD:1319889 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ENTPD4 mRNA | CTD | PMID:28628672 | methylparaben | increases expression | ISO | RGD:1319889 | 6480464 | methylparaben results in increased expression of ENTPD4 mRNA | CTD | PMID:31745603 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of ENTPD4 mRNA | CTD | PMID:24136188 | nickel dichloride | decreases expression | ISO | RGD:1319889 | 6480464 | nickel chloride results in decreased expression of ENTPD4 mRNA | CTD | PMID:17312168 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ENTPD4 mRNA | CTD | PMID:33387578 | PCB138 | multiple interactions | ISO | RGD:1319890 | 6480464 | [2 more ... | CTD | PMID:25510870 | pirinixic acid | decreases expression | ISO | RGD:1319890 | 6480464 | pirinixic acid results in decreased expression of ENTPD4 mRNA | CTD | PMID:17426115 | potassium chromate | decreases expression | ISO | RGD:1319889 | 6480464 | potassium chromate(VI) results in decreased expression of ENTPD4 mRNA | CTD | PMID:22714537 | SB 431542 | multiple interactions | ISO | RGD:1319889 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sunitinib | increases expression | ISO | RGD:1319889 | 6480464 | Sunitinib results in increased expression of ENTPD4 mRNA | CTD | PMID:31533062 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ENTPD4 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of ENTPD4 mRNA | CTD | PMID:31150632 | tetrodotoxin | multiple interactions | EXP | | 6480464 | [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of ENTPD4 mRNA | CTD | PMID:22341215 | trichostatin A | decreases expression | ISO | RGD:1319889 | 6480464 | trichostatin A results in decreased expression of ENTPD4 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:1319889 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENTPD4 mRNA | CTD | PMID:27188386 | valproic acid | affects expression | ISO | RGD:1319889 | 6480464 | Valproic Acid affects the expression of ENTPD4 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | RGD:1319889 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENTPD4 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | ISO | RGD:1319889 | 6480464 | Valproic Acid results in decreased expression of ENTPD4 mRNA | CTD | PMID:23179753 more ... | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of ENTPD4 mRNA | CTD | PMID:23034163 | Yessotoxin | increases expression | ISO | RGD:1319889 | 6480464 | yessotoxin analog results in increased expression of ENTPD4 mRNA | CTD | PMID:30679557 | |